Preparation method of reductive-response amphipathic wormlike monomolecular prodrug

An amphiphilic, worm-like technology, used in pharmaceutical formulations, organic active ingredients, and non-active ingredients medical preparations, etc., can solve the problems of uncontrollable release, low drug loading rate, poor selectivity, etc., and achieve enhanced internalization. effect, enhanced upload capacity and selective release

Active Publication Date: 2017-08-11
SOUTHWEST UNIVERSITY
View PDF2 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In view of this, one of the objectives of the present invention is to provide a reduction-responsive amphiphilic worm-like single-molecule prodrug for the defects of poor selectivity, uncontrollable release, and low drug loading rate of existing single-molecule anti-tumor drugs. Preparation method and its application in the field of drug treatment of cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of reductive-response amphipathic wormlike monomolecular prodrug
  • Preparation method of reductive-response amphipathic wormlike monomolecular prodrug
  • Preparation method of reductive-response amphipathic wormlike monomolecular prodrug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1 Preparation of reductively responsive amphiphilic worm-like single-molecule prodrug DCO-SS

[0028] (1) Preparation of CPT precursor CPT-SS with reductive response: Under argon (Ar) atmosphere, ① 2-hydroxyethyl disulfide (BHD, 6.25g, 40.5mmol), methacryloyl chloride ( 2.2mL, 22.73mmoL, dissolved in 15 mL of anhydrous THF, slowly added dropwise to the system), tetrahydrofuran (THF, 50mL) and triethylamine (TEA, 3.3mL, 24mmoL) were mixed and stirred overnight, column purified to obtain MABHD; ② CPT (1.39g, 4mmoL), triphosgene (BTC, 500mg, 1.685mmoL, dissolved in 10mL anhydrous DCM, slowly added dropwise to the system), 4-dimethylaminopyridine (DMAP, 1.56g, 11.3mmoL ) mixture was dispersed into 60mL of anhydrous DCM, reacted for 30min, then added dropwise MABHD (976mg, 2.375mmoL, dissolved in 10 mL of anhydrous THF, slowly added dropwise to the system), stirred overnight, and purified to obtain the precursor CPT- SS;

[0029](2) Preparation of the drug initiato...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of reductive-response amphipathic wormlike monomolecular prodrug. On the basis of linear structure of glucan, stimulus response of high-concentration glutathione in tumor cells is utilized to promote splitting of disulfide bonds of the amphipathic wormlike monomolecular prodrug to realize synchronous release of camptothecin (CPT) which is antitumor drug so as to act on a tumor position. The preparation method includes following steps: (1), preparing camptothecin monomer: specifically introducing disulfide-bond camptothecin CPT-SS; (2), preparing a drug initiator DEX-Br; (3), polymerizing the camptothecin monomer CPT-SS on the initiator through atom transfer radical polymerization (ATRP) to obtain a DEX-CPT-SS hydrophobic intermediate product; (4), utilizing ATRP to polymerize polyethylene glycol methacrylate (OEGMA) to obtain amphipathic segmented polymer DEX-CPT-OEGMA-SS named as DCO-SS. The obtained amphipathic wormlike monomolecular prodrug can directly form a drug monomolecular micelle in an aqueous phase, has the advantages of high drug loading capacity (higher than 23wt%), high micelle stability, sensitive stimulus-response drug release, high biocompatibility and low toxic and side effect on normal tissue. The problem that hydrophobic drug is low in molecular solubility is solved effectively, and an efficient drug delivery carrier is provided.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a preparation method of a reduction-responsive amphiphilic worm-like single-molecule prodrug and its application in the field of drug treatment of cancer. Background technique [0002] Dextran (Dextran, also known as dextran, a polysaccharide, molecular formula (C6H10O5) n, CAS number: 9004-54-0), dextran can replace a part of whole blood during blood transfusion, as a plasma volume expander ( called plasma substitute). Commercial plasma substitutes are partially hydrolyzed dextran dissolved in normal saline. Therefore, dextran has good biocompatibility, is harmless to the human body, and is biodegradable. It is a good carrier material for anticancer drugs. Camptothecin (CPT, chemical structure: C 20 h 16 N 2 o 4 , CAS No.: 7689-03-4, relative molecular weight: 348.43) is a plant anticancer drug extracted from camphor trees distributed in south-central and sout...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C08F293/00C08F220/28C08F220/38A61K47/61A61K31/4745A61P35/00
CPCA61K31/4745C08F220/28C08F220/286C08F220/38C08F220/387C08F293/00
Inventor 许志刚白霜侯美丽石潇潇
Owner SOUTHWEST UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products